InvestorsHub Logo
Followers 28
Posts 4372
Boards Moderated 1
Alias Born 09/22/2006

Re: maumar post# 7245

Friday, 11/11/2022 3:19:42 PM

Friday, November 11, 2022 3:19:42 PM

Post# of 8691
I agree about the macro picture and biotech in general being risk on. A 20% HALO move in a week or so is still a little heady here IMHO. Was the Amivantamab news really that surprising? Normally a move into Phase 3 is not going to get everyone that amped up. Was this an undisclosed indication up until now?

The more you know, the less you don't know.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HALO News